- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03244501
Transcranial Static Magnetic Field Stimulation of Frontal Cortex
Modulation of Frontal Cortical Activity With Transcranial Static Magnetic Field Stimulation
Study Overview
Detailed Description
The investigator's primary objective is to determine the feasibility of modifying frontal brain activity using static magnetic fields. The investigator's will be examining the effects of static magnetic field of the spectral power of EEG data with healthy human participants.
This is a within-subjects design, where each participant will receive sham and active stimulation on the left and right frontal cortex. EEG data will be collected during each stimulation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27514
- UNC Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Right-handed, healthy, 18+ years old
- Capacity to understand all relevant risks and potential benefits of the study (informed consent)
- Willing to comply with all study procedures and be available for the duration of the study - Speak and understand English
Exclusion Criteria:
- Medical history of Psychological/Emotional Disorders (depression, anxiety, bipolar, etc.)
- (For females) Pregnancy or breast feeding
- Diagnosis of eating disorder (current or within the past 6 months)
- Diagnosis of Obsessive-Compulsive Disorder (lifetime) Attention Deficit Hyperactivity Disorder (currently under treatment)
- Neurological disorders and conditions, including, but not limited to:
- History of epilepsy
- Seizures (except childhood febrile seizures and Electroconvulsive therapy-induced seizures)
- Dementia
- History of stroke
- Parkinson's disease
- Multiple sclerosis
- Cerebral aneurysm
- Brain tumors
- Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment)
- Prior brain surgery Any brain devices/implants, including cochlear implants and aneurysm clips
- Any metal in/on the body, e.g., dental braces, glasses, piercings
- Traumatic brain injury
- Thick hair that would create distance between the magnet and the scalp
- Taking hormonal birth control or hormonal supplements (e.g., testosterone injections) - Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Left Frontal
An active magnet (active tSMS) will be placed over the left frontal cortex, while a sham magnet (sham tSMS, a nonmagnetic metal cylinder made of brass) will be placed over the right frontal cortex.
|
A cylindrical neodymium magnet is placed above the scalp.
|
Experimental: Right Frontal
An active magnet (active tSMS) will be placed over the right frontal cortex, while a sham magnet (sham tSMS, a nonmagnetic metal cylinder made of brass) will be placed over the left frontal cortex.
|
A cylindrical neodymium magnet is placed above the scalp.
|
Sham Comparator: Sham Frontal
Sham magnets (sham tSMS, a nonmagnetic metal cylinder made of brass) will be placed over the left and right frontal cortex.
|
A cylindrical piece of nonferrous metal (brass).
This is not attracted to magnets, and is identical in weight and appearance to active magnets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Electroencephalogram (EEG) Spectral Power
Time Frame: 4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulation
|
Changes in the spectral power of the EEG before (2 min eyes-closed, 2 min eyes-open), during (eyes-open), and after stimulation (eyes-open)
|
4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Rate Variability
Time Frame: 4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulation
|
Change in the ratio between the power in low frequency band and the power in high frequency band.
As this outcome variable is a ratio between two items that are measured in microvolt^2, the ratio does not have a unit of measure.
|
4 minutes before stimulation, 10 minutes during stimulation, and 2 minutes after stimulation
|
Collaborators and Investigators
Investigators
- Study Director: Flavio Frohlich, PhD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-1022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Active tSMS
-
Campus Bio-Medico UniversityRecruitingAmyotrophic Lateral SclerosisItaly
-
University of CalgaryCompletedHealthy | PediatricsCanada
-
Universidad Rey Juan CarlosRecruitingStroke | Neurologic Disorder | Manual DexteritySpain
-
Neuromed IRCCSNot yet recruitingProgressive Multiple SclerosisItaly
-
University of Sao PauloCompletedMusculoskeletal Pain | Parkinson DiseaseBrazil
-
University of SevilleCompleted
-
Fundación de investigación HMMichael J. Fox Foundation for Parkinson's Research; Hospital San Carlos, Madrid and other collaboratorsCompletedParkinson's Disease | Dyskinesia, Medication-InducedSpain
-
Unilever R&DCompleted
-
Novozymes A/SAnalyze & RealizeNot yet recruiting